Precision Diagnostics

Uncover
all diseases

Muno reads your body's molecular signals to find what current tests miss.

Investor Inquiry
Current Pipeline
Long COVID Molecular Subtyping Test
First-in-class subtyping test to stratify long COVID patients by immune signature
PDB 7S4S · SARS-CoV-2 RBD–Antibody Complex

Your body already knows what's wrong. Your immune system, your proteins, your metabolism. Together they form a continuous map of what's happening inside you. Today, medicine reads only a fraction of that map, a few markers at a time. Millions wait years for answers that should have been theirs from the first draw of blood. We're building the technology to read the whole map. Starting where the gap is widest: complex chronic illness, where the people who need the most insight have the least access to it. Our goal is to map every signal, in every patient. Finally surfacing the patterns that have always been there.

Team

We're building an
industry best team

Jo Teichmann
Jo Teichmann
Co-Founder & CEO
Serial entrepreneur in digital health
Linda Lan, PhD
Linda Lan, PhD
Co-Founder & CSO
Immunologist, Snyder Lab postdoc at Stanford
Michael Snyder, PhD
Michael Snyder, PhD
Scientific Co-Founder
Stanford Genetics, pioneer of multi-omic precision medicine
Michelle Roeding
Michelle Roeding
Regulatory Advisor
Former Senior Director Regulatory Affairs, Natera
Robyn Schlicher, PhD
Robyn Schlicher, PhD
Regulatory Advisor
Ex-Natera, ex-Abbott — brought multiple novel diagnostics to market

The future of diagnostics
starts here

Investor inquiry →